The most common side effects include nausea, upset stomach, constipation, fatigue, and headaches, which typically resolve with time
did not observe significant differences in amputation risk between GLP-1 receptor agonists, SGLT-2 inhibitors, and other diabetes medications in a large retrospective cohort study of 1,222,436 patients with type 2 diabetes
Learn more about our treatment options for Wegovy, Ozempic, and GLP-1 medications, or explore Mounjaro through our personalized weight loss plans
Cajon Blvd, San Bernardino, CA 92407, USA Review counts shown on landing page: 10,978 and 10,257 (inconsistent, both brand-reported) Regulatory category: marketed as a dietary supplement
Improves blood sugar control and reduces cardiovascular risk